U.S. stocks rallied on Monday as the U.S. dollar eased back from its recent peak and worries eased about the timing of a Federal Reserve interest rate hike.
Breaking News
Novartis said on Friday its experimental psoriasis drug Cosentyx was better at clearing the rough skin patches associated with the disease than Johnson & Johnson's Stelara.
Amgen acquires Onyx Pharmaceuticals for $10.4 billion.
After its rejection of the Amgen bid, Onyx is now fielding bids from Bayer and other pharmaceutical firms.
Onyx Pharmaceuticals Inc stated that it has rejected the unsolicited bid from Amgen Inc priced at US$120 per share piece.
Amgen announced an offered acquisition for biotech Onyx Pharmaceuticals at US$120 per share piece.
Subscribe to VCpost newsletter
Most Popular
- Walgreens to Open a New Pharmacy Offering Cell and Gene Therapies to Patients With Chronic Diseases Like Cancer
- Walmart Founder's Son Rob Walton to Step Down From Board
- How to Apply for Social Security Spousal Benefits; Here's How You May Boost Your Money!
- How to Get IRS Unclaimed Tax Refunds: Here's What to Do If You Think You Have Pending Payments
- Doctors Raise Concerns Over Proposed Capital Gains Tax Changes
- US Secretary of State Antony Blinken Calls on China to Treat American Companies Fairly During Visit to Shanghai
- Kroger and Albertsons to Sell off 166 Stores in Effort to Gain Approval for Their $25 Billion Merger
- 3.6 Million Medicare Beneficiaries Could Now Get Wegovy Coverage; Here's How!
